Evidence map›Paper›PMID 30784236›Full record

ArticleMolecular genetics & genomic medicine2019

The spectrum of genetic variants and phenotypic features of Southeast Asian patients with Noonan syndrome.

Ai-Ling Koh, Ee-Shien Tan, Maggie S Brett, Angeline H M Lai, Saumya Shekhar Jamuar, Ivy Ng, Ene-Choo Tan

Open access · goldAbstract read
In one paragraph

Article in Molecular genetics & genomic medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Ai-Ling KohDepartment of Paediatrics, KK Women's & Children's Hospital, Singapore.
Ee-Shien TanGenetics Service, Department of Paediatrics, KK Women's & Children's Hospital, Singapore.
Maggie S BrettResearch Laboratory, KK Women's & Children's Hospital, Singapore.
Angeline H M LaiGenetics Service, Department of Paediatrics, KK Women's & Children's Hospital, Singapore.
Saumya Shekhar JamuarGenetics Service, Department of Paediatrics, KK Women's & Children's Hospital, Singapore.
Ivy NgGenetics Service, Department of Paediatrics, KK Women's & Children's Hospital, Singapore.
Ene-Choo TanGenetics Service, Department of Paediatrics, KK Women's & Children's Hospital, Singapore.ORCID 0000-0001-5497-6058
SingHealth Duke-NUS Academic Medical Centre · SGKK Women's and Children's Hospital · SG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNoonan syndrome (NS) is an autosomal dominant disorder that belongs to a group of developmental disorders called RASopathies with overlapping features and multiple causative genes. The aim of the study was to identify mutations underlying this disorder in patients from Southeast Asia and characterize their clinical presentations.

methodsPatients were identified from the hospital's Genetics clinics after assessment by attending clinical geneticists. A targeted gene panel was used for next-generation sequencing on genomic DNA extracted from the blood samples of 17 patients.

resultsHeterozygous missense variants were identified in 13 patients: eight were in PTPN11, three in SOS1, and one each in RIT1 and KRAS. All are known variants that have been reported in patients with NS. Of the 13 patients with identified variants, 10 had short stature, the most common feature for NS. Four of the eight patients with PTPN11 variants had atrial septal defect. Only two had pulmonary stenosis which is reported to be common for PTPN11 mutation carriers. Another two had hypertrophic cardiomyopathy, a feature which is negatively associated with PTPN11 mutations.

conclusionsOur study provides the mutation and phenotypic spectrum of NS from a new population group. The molecular testing yield of 76% is similar to other studies and shows that the targeted panel approach is useful for identifying genetic mutations in NS which has multiple causative genes. The molecular basis for the phenotypes of the remaining patients remains unknown and would need to be uncovered via sequencing of additional genes or other investigative methods.

Indexed as

Mutation RatePhenotypeChildChild, PreschoolFemaleHumansInfantMaleMutation, MissenseNoonan SyndromeProtein Tyrosine Phosphatase, Non-Receptor Type 11Proto-Oncogene Proteins p21(ras)ras ProteinsSingaporeSOS1 ProteinKRAS protein, humanProtein Tyrosine Phosphatase, Non-Receptor Type 11Proto-Oncogene Proteins p21(ras)PTPN11 protein, humanras ProteinsRIT1 protein, humanSOS1 Proteingenetic testingmolecular diagnosisNoonan syndromeRASopathies

Identifiers

PMID30784236
PMCPMC6465663
OpenAlexW2916585287

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.